¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antibody identification test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • minimal nerve excitability test
    ÃּҽŰæÀڱذ˻ç
  • minimal stimulating test
    ¹Ì¾àÁÖÀÔÀڱؽÃÇè
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • monaural loudness balance test
    ´ÜÀÌÀ½ÆòÇü°Ë»ç
  • mucin clot test
    Á¡¾×ÀÀ°í°Ë»ç
  • multiphasic screening test
    ´Ù»ó¼±º°°Ë»ç
  • multiple sleep latency test
    ¼ö¸éÀẹ±â¹Ýº¹°Ë»ç
  • multistage exercise test
    ´Ù´Ü°è¿îµ¿°Ë»ç
  • nerve excitability test
    ½Å°æÀڱذ˻ç
  • neutralization test
    ÁßÈ­°Ë»ç
  • night penile tumescence test
    ¼ö¸éÀ½°æÆØÃ¢°Ë»ç
  • nonparametric test
    ºñÁöÇ¥°ËÁ¤
  • objective hearing test
    Ÿ°¢Ã»·Â°Ë»ç, °´°üÀûû·Â°Ë»ç
  • occlusion test
    ¸Â¹°¸²°Ë»ç, ±³ÇÕ°Ë»ç
  • occult blood test
    ÀáÇ÷°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Paigen test
    ÆÄÀ̰սÃÇè
  • Paul-Bunnell test
    Æú-¹ø³Ú °Ë»ç¹ý
  • Paul-Bunnell-Davidsohn test
    Æú-¹ö³Ú-´Ùºñµå¼Õ ½ÃÇè
  • Perls iron test
    Æä¸¦Áîö½ÃÇè
  • Phenstix test
    Ææ½ºÆ½½º°Ë»ç
  • Prausnitz-Kustner test
    ÇÁ¶ó¿ì´ÏÃ÷-Äû½ºÆ®³Ê½ÃÇè.
  • Prausnitz-Kustner test
    ÇÁ¶ó¿ì½º´ÏÃ÷ Äû½ºÆ®³Ê °Ë»ç
  • Prausniz-K stner test
    ÇÁ¶ó¿ì½º´ÏÃ÷-Äû½ºÆ®³Ê½ÃÇè
  • Quellung test
    Çù¸·ÆØÃ¢½ÃÇè(úúدø³óìãËúÐ).
  • RAST => radioallergosorbent test
    ¹æ»ç¾Ë·¹¸£°ÕÈíÂø½ÃÇè
  • Randot stereo test
    ¶õµµÆ®ÀÔü½Ã°Ë»ç
  • Reiner d-xylose absorption test
    ¶óÀÌ³Ê d-½Ç·Î½ºÈí¼ö½ÃÇè
  • Rinne test
    ¸°³×°Ë»ç
  • Roger test
    ·ÎÀú½ÃÇè
  • Romberg test
    ·Ò¹ö±×°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • theory, instruction [of antibody]
    Áö·É¼³ (Ç×ü»ý»ê)
  • thyroglobulin antibody
    Ƽ·Î±Û·ÎºÒ¸°Ç×ü(¡­ù÷ô÷).
  • tissue antibody
    Á¶Á÷Ç×ü
  • titer, antibody
    Ç×ü°¡
  • tumor immunity,antibody-based therapy
    Ç×ü¿¡ ÀǰÅÇÑ Ä¡·á
  • type I << antibody excess >>
    IÇü << Ç×ü°úÀ× >>
  • univalent antibody
    Àϰ¡Ç×ü(ìéʤù÷ô÷).
  • viral antibody
    ¹ÙÀÌ·¯½º Ç×ü
  • virus neutralizing antibody
    ¹ÙÀÌ·¯½º ÁßÈ­Ç×ü
  • virus neutralizing antibody
    ¹ÙÀÌ·¯½ºÁßÈ­Ç×ü(¡­ñéûúù÷ô÷).
  • warm antibody
    ¿ÂÇ×ü(è®ù÷ô÷), ¿Â³­Ç×ü(è®Ñìù÷ô÷).
  • warm-antibody autoimmune hemolytic anemia
    ¿Â³­Ç×üÀÚ°¡¸é¿ª¼º¿ëÇ÷¼ººóÇ÷
  • abrasion test
    ¸¶¸ê½ÃÇè(بØþãËúÐ).
  • absorption test
    Èí¼ö½ÃÇè
  • absorption test, agglutinin
    ÀÀÁý¼Ò Èí¼ö½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
AGCT antiglobulin consumption test; Army General Classification Test
AITT arginine insulin tolerance test; augmented insulin tolerance test
ART absolute retention time; Accredited Record Technician; acoustic reflex test; algebraic reconstructio...
BG basal ganglion; basic gastrin; Bender Gestalt [test]; beta-galactosidase; beta-glucuronidase; bicolo...
BST bacteriuria screening test; blood serologic test; brief stimulus therapy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
scFvs Single chain Fv antibody fragments
ScFv single chain antibody fragment
SMA Smooth muscle antibody
TRAb TSH receptor antibody
TSAb Thyroid Stimulating Antibody
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Hanger's test
    Çà°Å ½ÃÇè
    1. °£ ¼¼Æ÷ ÁúȯÀÌ ÀÖÀ¸¸é ¼¼ÆÈ¸° ÄÝ·¹½ºÅ×·Ñ À¯Å¹¾×¿¡ ¸é»ó ¹ÝÀÀÀÌ »ý±â´Â Çö»óÀ» ÀÌ¿ëÇÑ ½ÃÇè. 2. ÀÌ ÁúȯÀÇ Ç÷û¿¡ ÀÇÇØ¼­ ¼¼ÆÈ¸°-ÄÝ·¹½ºÅ×·Ñ
  • hapten inhibition test
    ÇÕÅÙ ÀúÇØ ½ÃÇè
    Ç×üÀÇ Ç׿ø Ư¼ö °áÇÕ ºÎÀ§¸¦ µ¤´Â ÇÕÅÙÀ» ÀÌ¿ëÇÏ¿© Ç׿ø °áÁ¤±âÀÇ Ç÷ûÇÐÀû Ư¼ºÀ» °Ë»çÇÏ´Â ½ÃÇè.
  • Harris and Ray test
    Ç츮½º-·¹ÀÌ ½ÃÇè
    ¿äÁßÀÇ ºñŸ¹Î C¿¡ ´ëÇÑ ¹Ì·® ÀûÁ¤¹ý.
  • heel to knee to shin test
    Á¾½½°æ ½ÃÇè
  • hemadsorption test
    Ç÷±¸ ÈíÂø ½ÃÇè
    Ç÷±¸ ÀÀÁý¼Ò Á¸Àç ½Ã¿¡ ÀûÇ÷±¸°¡ °¨¿°µÈ Á¶Á÷ÀÇ ¼¼Æ÷¿¡ À¯ÂøµÈ´Ù´Â »ç½ÇÀ» ±âÃÊ·Î ÇÏ¿© Ç÷±¸ ÀÀÁý¼º ¹ÙÀÌ·¯½º¸¦ °ËÃâÇÏ´Â »ýü¿Ü ½ÃÇè¹ýÀÌ´Ù.
  • hemagglutination inhibition test
    ÀûÇ÷±¸ ÀÀÁý ¾ïÁ¦ ½ÃÇè
  • hemaggutination test
    ÀûÇ÷±¸ ÀÀÁý ½ÃÇè
  • hematoporphyrin test
    Ç츶ÅäÆ÷¸£ÇǸ° ½ÃÇè
  • hemosiderin test
    Çì¸ð½Ãµ¥¸° Å×½ºÆ®, Ç÷ö¼Ò ½ÃÇè
  • Henry fructose test
    Ç °ú´ç °Ë»ç
  • Henshaw test
    Çî¼î¿ì ½ÃÇè
    ÁÖ¾îÁø Áúȯ¿¡ ´ëÇÑ Àû´çÇÑ È£¸Þ¿ÀÆÄƼ Ä¡·á ¾àÀÇ ¼±ÅÃÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â °Ë»ç¹ý .ÀÌ Áúȯ¿¡ ´ëÇÏ¿© È£¸Þ¿ÀÆÄƼÀûÀ¸·Î Áö½ÃµÈ °­È­ Ä¡·á¾à¿¡ ÇǰËÀÚÀÇ Ç÷ûÀ» Á¢Ã˽ÃÄ×À» ¶§ ´«¿¡ º¸ÀÌ´Â ¸é»ó ¹ÝÀÀ´ë°¡ ¹ßÇöµÇ¸é ¾çÈ£ÇÑ °ÍÀÌ´Ù.
  • Herzberg's test
    Ç츣Âê¹ö±× ½ÃÇè
    À§¾× Áß¿¡ À¯¸® ¿°»êÀÌ Á¸ÀçÇϸé Äá°í·¹µå ¿ë¾×ÀÌ Ã»»öÀ» ¶ì´Â ½ÃÇè.
  • Heynsius'test
    ÇÏÀνÿ콺 ½ÃÇè
    Çǰ˾׿¡ ÃæºÐÇÑ ¾çÀÇ ÃÊ»êÀ» °¡ÇÏ¿© »ê¼ºÀ¸·Î ¸¸µç ´ÙÀ½ ¿°È­ ³ªÆ®·ýÀÇ Æ÷È­ ¿ë¾×°ú ÇÔ²² ²úÀδÙ. ¾ËºÎ¹ÎÀÌ Á¸ÀçÇÏ¸é ¸é»ó ħÀüÀÌ »ý±ä´Ù.
  • Hildebrant's test
    Èúµ¥ºê¶õÆ® ½ÃÇè
    ¿äÁß¿¡ ¿ì·Îºô¸°ÀÌ ÀÖÀ¸¸é ÃÊ»ê ¾Æ¿¬°ú ¹«¼ö ¾ËÄÝ È¥ÇÕ¹°ÇÏ¿¡¼­ ³ì»ö Çü±¤À» ³ªÅ¸³»´Â ¹ÝÀÀ.
  • Hindenlang's test
    Èùµ¨¶û ½ÃÇè
    Çǰ˾׿¡ °íüÀÇ ¸ÞŸÆ÷½ºÆ÷¸¯»êÀ» °¡ÇßÀ» ¶§ ¾ËºÎ¹ÎÀÌ Á¸ÀçÇϸé ħÀü¹°ÀÌ »ý±â´Â ½ÃÇè.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
pentagastrin test An alternative to histamine for stimulation of acid secretion in gastric analysis.
(05 Mar 2000)
Gofman test A test for various serum lipoproteins that contain cholesterol, as an index of the tendency to the development of atheromatous lesions and arteriosclerosis; the test is based on the differential flotation of molecules of various sizes when the serum is treated in an ultracentrifuge.
(05 Mar 2000)
Meltzer-Lyon test A test used in diagnosis of gallbladder conditions: 25 ml of a 25% solution of magnesium sulfate are delivered into the region of the sphincter of Oddi through a duodenal tube, causing contraction of the gallbladder, relaxation of the sphincter, and the expulsion of bile from the common duct and gallbladder; bile from the common duct is relatively pale and is expelled first, that from the gallbladder follows; samples aspirated from the tube are examined for pus cells, pigment granules, epithelial cells, cholesterol, etc.
(05 Mar 2000)
Goldscheider's test Determination of the temperature sense by touching the skin with a sharp-pointed metallic rod, heated to varying degrees.
(05 Mar 2000)
gold sol test An obsolete, non-specific test for altered proteins in spinal fluid. As originally used by Lange in 1912, the test was thought to be specific for neurosyphilis; however, this proved to be incorrect. Dilutions of spinal fluid are made in saline and to these a colloidal gold solution is added; if altered proteins are present, there is a colour change or precipitate formed. at present, its chief use is to demonstrate cerebrospinal fluid protein abnormalities in multiple sclerosis.
Synonym: gold sol test, Zsigmondy's test.
(05 Mar 2000)
CF test <immunology> Binding of complement as a result of its interaction with immune complexes (the classical pathway) or particular surfaces (alternative pathway).
(18 Nov 1997)
Goodenough draw-alpha-man test A brief test for assessing an individual's level of intelligence based on how accurately drawn and how many elements are included when a child or adult is given a pencil and sheet of white paper and asked to draw a man, the best man he or she is able to draw. Also called the Goodenough draw-alpha-person test and, in its current form, the Goodenough-Harris drawing test.
(05 Mar 2000)
goodness of fit test A statistical test of the hypothesis that data have been randomly sampled or generated from a population that follows a particular theoretical distribution.
(05 Mar 2000)
Reuss' test A test for atropine; the addition of oxidizing agents and sulfuric acid to a liquid containing atropine produces an odour of orange-flowers and roses.
(05 Mar 2000)
performance test A test, such as five of the eleven Wechsler adult intelligence scale subtests, requiring little or no verbal instruction from the examiner and virtually no verbal response by the examinee.
(05 Mar 2000)
Gothlin's test <investigation> A capillary fragility test to determine the presence or absence of scurvy.
(05 Mar 2000)
Rh blocking test A test for nonagglutinating Rh antibodies: an Rh agglutination test is first carried out; if the test for Rh agglutinins is negative, then 1 drop of anti-Rho agglutinating serum of moderate titre is mixed with the patient's serum containing Rh-positive test cells; if after incubating for from 1 to 2 hr at 37°C no agglutination occurs, Rho-blocking antibodies are assumed to be present in the patient's serum.
(05 Mar 2000)
Graham-Cole test Radiography of the gallbladder after ingestion of a contrast medium.
(12 Dec 1998)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
Chick-Martin test A method of testing the in vitro efficiency of a bactericidal agent; a standard culture of Salmonella typhi which has been added to a fixed amount of sterilised faeces or yeast is tested for a fixed period (30 minutes), against various concentrations of phenol solution and various concentrations of the disinfectant; the result is expressed as a ratio: the phenol coefficient, which is the highest dilution of the disinfectant under test at which the bacteria are killed, divided by the highest dilution of phenol which sterilises the solution in the same length of time.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á